Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280372![]() (US10030012, Example 2 | ethyl 4-(4-{1- [(cyclohexy...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.87E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280375![]() (US10030012, Example 5 | ethyl 4-{4-[5-(4- chloroph...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280385![]() (US10030012, Example 15 | ethyl 4-(4-(5- isopropyl-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.28E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280393![]() (US10030012, Example 23 | ethyl 4-{4-[5- (methoxy- ...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280398![]() (US10030012, Example 28 | ethyl 4-{4-[5- (acetamido...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.48E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280402![]() (US10030012, Example 32 | ethyl 4-[4-(6- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 220 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280413![]() (US10030012, Example 43 | ethyl 4-{4-[2- methoxy-5-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280417![]() (US10030012, Example 47 | ethyl 4-[4-(2- ethoxy-5-m...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 160 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280425![]() (US10030012, Example 55 | ethyl 4-{4-[2- (propan-2-...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280428![]() (US10030012, Example 58 | ethyl 4-[4-(5- chloro-2- ...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280435![]() (US10030012, Example 65 | ethyl 4-{4-[2- (dimethyla...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280440![]() (US10030012, Example 70 | ethyl 4-[4-(2- ethylpyrid...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280451![]() (US10030012, Example 81 | ethyl (4S)-4-[4- (1H-pyra...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 85 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280371![]() (US10030012, Example 1 | ethyl 4-[4- (1-methyl- 1H-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.36E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280377![]() (US10030012, Example 7 | ethyl 4-{4-[5-(1- methyl-1...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 260 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280378![]() (US10030012, Example 8 | ethyl 4-{4-[4-(4- chloroph...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280394![]() (US10030012, Example 24 | ethyl 4-(4-{5- [(cyclopro...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.37E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280404![]() (US10030012, Example 34 | ethyl 4-[4-(2- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280408![]() (US10030012, Example 38 | ethyl 4-[4-(3- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280415![]() (US10030012, Example 45 | ethyl 4-[4-(5- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 460 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280431![]() (US10030012, Example 61 | ethyl 4-(4-{2- [1-(propan...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 150 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280439![]() (US10030012, Example 69 | ethyl 4-{4-[5- (trifluoro...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 630 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280442![]() (US10030012, Example 72 | ethyl 4-[4-(6- ethoxypyri...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.02E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280444![]() (US10030012, Example 74 | ethyl 4-[4- (pyrimidin-2-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.05E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280445![]() (US10030012, Example 75 | ethyl 4-[4-(4- methylpyri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.01E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280373![]() (US10030012, Example 3 | ethyl 4-[4-(1H- pyrrol-1- ...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 330 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280374![]() (US10030012, Example 4 | ethyl 4-[4-(1H- pyrazol-1-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 140 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280382![]() (US10030012, Example 12 | ethyl 4-[4-(5- methyl-1H-...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280387![]() (US10030012, Example 17 | ethyl 4-{4-[3- (thiophen-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 810 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280390![]() (US10030012, Example 20 | ethyl 4-[4-(5- cyclopropy...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.26E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280397![]() (US10030012, Example 27 | ethyl 4-[4-(5- cyano-1H- ...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 320 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280405![]() (US10030012, Example 35 | ethyl 4-[4-(2- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 30 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280413![]() (US10030012, Example 43 | ethyl 4-{4-[2- methoxy-5-...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280418![]() (US10030012, Example 48 | ethyl 4-[4-(4- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 250 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280422![]() (US10030012, Example 52 | ethyl 4-{4-[2- (difluoro-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280426![]() (US10030012, Example 56 | ethyl 4-{4-[1- (cyanometh...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.35E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280442![]() (US10030012, Example 72 | ethyl 4-[4-(6- ethoxypyri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 270 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280443![]() (US10030012, Example 73 | ethyl 4-{4-[2- (1-methyl-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 650 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280447![]() (US10030012, Example 77 | ethyl 4-{4-[2- (2-methyl-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 670 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280448![]() (US10030012, Example 78 | methyl 4-{[3- (3,5-dimeth...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.68E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280452![]() (US10030012, Example 82 | ethyl (4R)-4-[4- (1H-pyra...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 460 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280454![]() (US10030012, Example 85 | ethyl (4S)-4-[4- (2-metho...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 26 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280379![]() (US10030012, Example 9 | ethyl 4-[4-(1- methyl-1H- ...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.05E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280381![]() (US10030012, Example 11 | ethyl 4-[4-(1- propyl-1H-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 960 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280390![]() (US10030012, Example 20 | ethyl 4-[4-(5- cyclopropy...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280391![]() (US10030012, Example 21 | ethyl 4-{4-[5- (dimethyl-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.68E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280419![]() (US10030012, Example 49 | ethyl 4-{4-[3- (dimethyla...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280427![]() (US10030012, Example 57 | ethyl 4-[4-(1- ethyl-2-ox...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 890 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280432![]() (US10030012, Example 62 | ethyl 4-{4-[2- (methylami...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 360 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280433![]() (US10030012, Example 63 | ethyl 4-[4-(5- methoxy-2-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 560 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280437![]() (US10030012, Example 67 | ethyl 4-(4-{2- [(cyclopro...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 990 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280438![]() (US10030012, Example 68 | ethyl 4-[4-(1,3- thiazol-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 540 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280444![]() (US10030012, Example 74 | ethyl 4-[4- (pyrimidin-2-...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280382![]() (US10030012, Example 12 | ethyl 4-[4-(5- methyl-1H-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 520 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280406![]() (US10030012, Example 36 | ethyl 4-[4-(2- methylpyri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 6.73E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280408![]() (US10030012, Example 38 | ethyl 4-[4-(3- methoxypyr...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 160 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280422![]() (US10030012, Example 52 | ethyl 4-{4-[2- (difluoro-...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280423![]() (US10030012, Example 53 | ethyl 4-[4-(2- ethoxypyri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 60 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280436![]() (US10030012, Example 66 | ethyl 4-[4-(2- cyclopropy...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280439![]() (US10030012, Example 69 | ethyl 4-{4-[5- (trifluoro...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280441![]() (US10030012, Example 71 | ethyl 4-[4-(4- methoxy- p...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.05E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280376![]() (US10030012, Example 6 | ethyl 4-[4-(1H- pyrazol-3-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280380![]() (US10030012, Example 10 | ethyl 4-[4- (1-ethyl- 1H-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280386![]() (US10030012, Example 16 | ethyl 4-[4- (3-methyl- 1H...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 400 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280388![]() (US10030012, Example 18 | ethyl 4-{4-[4-(4- fluorop...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 410 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280395![]() (US10030012, Example 25 | ethyl 4-{4-[5- (dimethyl-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 270 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280399![]() (US10030012, Example 29 | ethyl 4-{[3- (1H-pyrazol-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.83E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280400![]() (US10030012, Example 30 | ethyl 4- [4-(pyridin- 4-y...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.66E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280401![]() (US10030012, Example 31 | ethyl 4- [4-(pyridin-4- y...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.26E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280407![]() (US10030012, Example 37 | ethyl 4-[4-(4,6- dimethox...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 3.34E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280410![]() (US10030012, Example 40 | ethyl 4-[4-(3- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 140 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280416![]() (US10030012, Example 46 | ethyl 4-[4-(2- methylpyri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.55E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280425![]() (US10030012, Example 55 | ethyl 4-{4-[2- (propan-2-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 130 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280429![]() (US10030012, Example 59 | ethyl 4-[4-(3,6- dimethyl...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 530 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280446![]() (US10030012, Example 76 | ethyl 4-{4-[2- (1,3-thiaz...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280450![]() (US10030012, Example 80 | ethyl 4-{4-[2- (1,3-oxazo...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 850 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280373![]() (US10030012, Example 3 | ethyl 4-[4-(1H- pyrrol-1- ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.54E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280377![]() (US10030012, Example 7 | ethyl 4-{4-[5-(1- methyl-1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280384![]() (US10030012, Example 14 | ethyl 4-[4-(1- methyl-1H-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280396![]() (US10030012, Example 26 | ethyl 4-[4-(1,3- thiazol-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 130 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280414![]() (US10030012, Example 44 | ethyl 4-[4-(3- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 370 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280424![]() (US10030012, Example 54 | ethyl 4-(4-{2-[(3- methyl...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280430![]() (US10030012, Example 60 | ethyl 4-{4-[5- methoxy-2-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280434![]() (US10030012, Example 64 | ethyl 4-{4-[2- (1-methyl-...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 3.14E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280449![]() (US10030012, Example 79 | ethyl 4-{[3-(3,5- dimethy...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 340 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280453![]() (US10030012, Example 83 | ethyl (4S)-4-[4- (1-methy...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280455![]() (US10030012, Example 86 | ethyl (4R)-4-[4- (2-metho...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 310 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280371![]() (US10030012, Example 1 | ethyl 4-[4- (1-methyl- 1H-...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280375![]() (US10030012, Example 5 | ethyl 4-{4-[5-(4- chloroph...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 250 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280383![]() (US10030012, Example 13 | ethyl 4-[4- methoxy-4- (1...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 2.88E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280386![]() (US10030012, Example 16 | ethyl 4-[4- (3-methyl- 1H...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | >1.00E+7 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280389![]() (US10030012, Example 19 | ethyl 4-(4-{1- [(cyclopro...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 1.51E+3 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280392![]() (US10030012, Example 22 | ethyl 4-(4-{5- [1-(propan...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M2 (Homo sapiens (Human)) | BDBM280392![]() (US10030012, Example 22 | ethyl 4-(4-{5- [1-(propan...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 680 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | US Patent US10030012 (2018) | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280403![]() (US10030012, Example 33 | ethyl 4-[4-(6- methoxypyr...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280409![]() (US10030012, Example 39 | ethyl 4-[4-(1- methyl-2-o...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 740 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280411![]() (US10030012, Example 41 | ethyl 4-[4-(2- methylpyri...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 260 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280412![]() (US10030012, Example 42 | ethyl 4-[4-(2- ethoxy-5-m...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280420![]() (US10030012, Example 50 | ethyl 4-{4-[6- (dimethyla...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 460 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M4 (HUMAN M3) | BDBM280421![]() (US10030012, Example 51 | ethyl 4-[4-(4- methoxy- p...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank GoogleScholar AffyNet ![]() | UniChem | n/a | n/a | n/a | n/a | 310 | n/a | n/a | n/a | n/a | |
Heptares Therapeutics Limited US Patent | Assay Description The functional activity of compounds at the M4 and M2 receptors was determined by measuring changes in the level of intracellular calcium ions caused... | US Patent US10030012 (2018) | |||||||||||
More data for this Ligand-Target Pair |